Tag: veterinary oncology

Vivos Inc.'s IsoPet® cancer therapy reports record Q1 2025 growth with 150% more treatments, new clinic certifications, and expanded therapeutic applications.

Vivos Inc. Expands IsoPet® Animal Cancer Division in 2025 Vivos Inc. (OTCQB: RDGL) strengthens its IsoPet® division in 2025 with the expansion of clinics, training...

Vivos Inc. advances with Reg A-1 filing to support human trials and expand animal therapies, reflecting growth potential and commitment to oncology innovation.